NCT05450731

Brief Summary

The aim of this study is to examine the effect of a 12-week exercise-based cardiac rehabilitation intervention on the recurrence of atrial fibrillation (AF) in patients at six- and twelve-months post-ablation procedure.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at below P25 for not_applicable atrial-fibrillation

Timeline
Completed

Started May 2022

Shorter than P25 for not_applicable atrial-fibrillation

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 14, 2022

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

June 21, 2022

Completed
20 days until next milestone

First Posted

Study publicly available on registry

July 11, 2022

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 14, 2023

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 13, 2024

Completed
Last Updated

February 20, 2024

Status Verified

February 1, 2024

Enrollment Period

1.1 years

First QC Date

June 21, 2022

Last Update Submit

February 15, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • The aim of this study is to examine the effect of a 12-week exercise-based cardiac rehabilitation intervention on the recurrence of atrial fibrillation (AF) in 40 patients at six- and twelve-months post-ablation procedure.

    Examine the effect of a 12-week exercise-based cardiac rehabilitation intervention on the recurrence of atrial fibrillation at 6- and 12-months post-ablation treatment.

    12 months after the first intake appointment

Study Arms (2)

cardiac rehabilitation intervention group

EXPERIMENTAL

Participants assigned to the intervention group will participate in pre-post assessments and a 12-week supervised exercise based cardiac rehabilitation program at a designated local Pulse Heart Institute Cardiac Rehabilitation program.

Other: 12-week supervised exercise based cardiac rehabilitation program

control group

NO INTERVENTION

Participants assigned to the control group will participate in pre-post assessments and will maintain usual care and current activity levels.

Interventions

12-week exercise-based cardiac rehabilitation intervention on the recurrence of atrial fibrillation (AF) in patients at six- and twelve-months post-ablation procedure.

cardiac rehabilitation intervention group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ● Adult patients 18 years and older.
  • Willing to participate in the study after randomization to either an intervention group (cardiac rehabilitation exercise) or a control group (usual care).
  • Able to attend two pre and post study clinic visits at a local designated Pulse Heart Institute cardiac rehab program.
  • If randomized to the cardiac rehab intervention group can attend exercise rehab visits for 3 x per week for 12 weeks (36 visits) at a designated Pulse cardiac rehab program.
  • Has an active email address and phone number.
  • Documented diagnosis of Paroxysmal and persistent Atrial Fibrillation.
  • Undergone ablation treatment and is at a minimum of 2 weeks post ablation status.
  • Compliant with medication therapy including medications for heart rate control and anticoagulant(s).

You may not qualify if:

  • ● Does not speak English.
  • Does not have clearance to participate in the study by their attending cardiologist.
  • Documented cardiovascular disease or pulmonary/respiratory disease that would qualify the patient for Cardiac, Pulmonary or Vascular Rehabilitation at a Pulse Heart Institute rehabilitation program.
  • Dementia or cognitive impairment.
  • Unable to participate in rehabilitation exercise due to physical limitations.
  • Greater than one prior ablation procedure
  • Long standing, chronic Atrial Fibrillation
  • Patients who have undergone posterior wall isolation ablation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tacoma General Hospital

Tacoma, Washington, 98415, United States

Location

MeSH Terms

Conditions

Atrial Fibrillation

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 21, 2022

First Posted

July 11, 2022

Study Start

May 14, 2022

Primary Completion

June 14, 2023

Study Completion

January 13, 2024

Last Updated

February 20, 2024

Record last verified: 2024-02

Locations